In This Article:
President-elect Donald Trump threatened higher tariffs against longtime ally Denmark over its ownership of Greenland as a Danish territory; Trump even floated the idea of the US purchasing Greenland.
Denmark-based pharmaceutical company Novo Nordisk (NVO) is a major company that could be heavily impacted if Trump were to impose such tariffs. Yahoo Finance senior health reporter Anjalee Khemlani explains Novo Nordisk's presence in the US, especially as a GLP-1 weight-loss drug manufacturer, and what US companies like Eli Lilly (LLY) could have to gain if tariffs were levied against Denmark producers.
Trump has proposed new tariff policy proposals that he could enact using the International Economic Emergency Powers Act (IEEPA).
To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.
This post was written by Luke Carberry Mogan.